Srikanth D.

Srikanth D. is an experienced professional in pharmacovigilance and safety risk management with a strong background in signal management and aggregate report writing. Currently serving as Associate Director and Safety Risk Management Lead at argenx since April 2023, Srikanth previously held positions at Covis Pharma, where responsibilities included leading product transition pharmacovigilance for acquisitions and divestments. Other notable roles include Senior Manager positions at AMAG Pharmaceuticals, where similar responsibilities were undertaken, and earlier experience at Celgene and PAREXEL focusing on drug safety and clinical trials. Srikanth holds a Master's degree in Biomedical Sciences from Long Island University and a Bachelor's degree in Pharmacy from Rajiv Gandhi University of Health Sciences.